Calliditas Therapeutics AB - stock earnings
CALT Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | -1.8 million USD | 44.8 million USD |
| 2023Q3 | -15.4 million USD | 27.0 million USD |
| 2023Q2 | -8.5 million USD | 24.8 million USD |
| 2023Q1 | -18.1 million USD | 18.5 million USD |
| 2022Q4 | -353414 USD | 41.2 million USD |
| 2022Q3 | -815141 USD | 23.3 million USD |
| 2022Q2 | -18.8 million USD | 6.3 million USD |
| 2022Q1 | -23.7 million USD | 3.4 million USD |
| 2021Q4 | -24.2 million USD | 3.4 million USD |
| 2021Q3 | 736486 USD | 22.6 million USD |
| 2021Q2 | -18.7 million USD | ? USD |
| 2021Q1 | -19.5 million USD | 45803 USD |
| 2020Q4 | -20.6 million USD | 48401 USD |
| 2020Q3 | -15.4 million USD | ? USD |
| 2020Q2 | -6.6 million USD | ? USD |
| 2020Q1 | -6.4 million USD | 47293 USD |
| 2019Q4 | -2.5 million USD | 5.0 million USD |
| 2019Q3 | -5.1 million USD | ? USD |
| 2019Q2 | 9.0 million USD | 14.9 million USD |
| 2019Q1 | -4.6 million USD | ? USD |
| 2018Q4 | -4.9 million USD | ? USD |
| 2018Q3 | -3.5 million USD | ? USD |
| 2018Q2 | -2.0 million USD | ? USD |
| 2018Q1 | -4.6 million USD | ? USD |
| 2017Q4 | -4.9 million USD | ? USD |
| 2017Q3 | -2.3 million USD | ? USD |
| 2017Q2 | -1.9 million USD | ? USD |
| 2017Q1 | -1.3 million USD | ? USD |
CALT Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -46.3 million USD | 119.8 million USD |
| 2022 | -39.6 million USD | 77.1 million USD |
| 2021 | -56.3 million USD | 25.3 million USD |
| 2020 | -52.8 million USD | 105758 USD |
| 2019 | -3.5 million USD | 19.8 million USD |
| 2018 | -14.7 million USD | 715000 USD |
| 2017 | -10.5 million USD | ? USD |
| 2016 | -6.3 million USD | ? USD |
| 2015 | -6.1 million USD | ? USD |
CALT
Price: $20
52 week price:
Earnings Per Share: -1.64 USD
P/E Ratio: -13.18
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 12700
Market Capitalization: 613.2 million